Webinar: Latest Developments in Ovarian Cancer 2023 - Professor Clare Scott
This webinar provides information about the latest developments in Ovarian cancer research, including some of the clinical trials that are currently underway and new therapies emerging for ovarian cancer.
In this webinar, we hear from Professor Clare Scott, Joint Division Head of Clinical Translation and a Laboratory Head at the Walter and Eliza Hall Institute of Medical Research and Medical Oncologist at Peter MacCallum Cancer Centre, Royal Melbourne and Royal Women's Hospitals. Professor Scott summarises what we know so far regarding HRD and why it matters to women. She discusses what some of the options may be for Australia in the coming years.
We also hear from Associate Professor Yoland Antill, a Medical Oncologist and Cancer Genetics specialist in Victoria with appointments at Cabrini, Monash Health and Frankston and Royal Melbourne Hospitals. Associate Professor Antill provides an update on current treatments for ovarian cancer and gives an overview on what we can look out for in the future.
We also hear from Rhonda Chapman, who was diagnosed with Stage 3a high grade serous ovarian cancer in September 2020. Rhonda has been on several clinical trials since her diagnosis and shares her experience of being involved in these trials.
We are extremely grateful for the funding received from AstraZeneca for this webinar.
No comments found